Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Lavee, J; Mulzer, J; Krabatsch, T; Marasco, S; McGiffin, D; Garbade, J; Schmitto, JD; Zimpfer, D; Potapov, EV.
An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems.
J Heart Lung Transplant. 2018; 37(12):1399-1402 Doi: 10.1016/j.healun.2018.08.008
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Zimpfer Daniel
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent - administration & dosage
Adult - administration & dosage
Aged - administration & dosage
Cardiomyopathies - mortality, therapy
Equipment Design - administration & dosage
Female - administration & dosage
Germany - administration & dosage
Heart Failure - mortality, therapy
Heart-Assist Devices - administration & dosage
Humans - administration & dosage
Male - administration & dosage
Middle Aged - administration & dosage
Prognosis - administration & dosage
Survival Rate - administration & dosage
Young Adult - administration & dosage

Find related publications in this database (Keywords)
bi-ventricular assist device
bi-ventricular failure
continuous flow ventricular assist device
left ventricular assist device
right ventricular assist device
total artificial heart
© Med Uni GrazImprint